Biotech Peer Review: Magenta onboards five new VPs; BioInvent is hunting for a new CEO
→ Following a $50 million series B in April, stem cell transplantation startup Magenta Therapeutics is filling some key roles in its leadership team. The company is taking on four new vice presidents and a senior vice president: Charlotte McDonagh, VP, biotherapeutics; Cindy Driscoll, VP, finance; Karen Nichols, VP, regulatory and quality; Manisha Pai, VP, investor relations and communications; and Zoran Zdraveski, SVP, chief legal officer and corporate secretary.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.